Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

NCT07154823 is registered in ClinicalTrials.gov with Tempus AI as lead sponsor.

NCT NCT07154823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07154823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Lead sponsor
Tempus AI
Phase
Observational
Overall status
Recruiting
Start date
January 27, 2026
Completion date
November 30, 2035
Enrollment
550 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukaemia (aml), follicular lymphoma ( fl)